Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee popliteal bypasses
Dorigo et al. 20121
Department of Vascular Surgery, University of Florence, Florence, Italy
Primary patency of GORE® PROPATEN® Vascular Graft
Patient characteristics
Characteristic | N | % |
---|---|---|
Arterial hypertension | 482 | 87% |
Diabetes | 253 | 46% |
Chronic renal failure | 82 | 15% |
History of smoking | 403 | 72% |
Hyperlipemia | 330 | 59% |
Coronary artery disease | 251 | 45% |
BK fem-pop | 414 | 75% |
Infrapopliteal | 142 | 26% |
TP trunk | 69 | 13% |
Anterior tibial | 27 | 5% |
Posterior tibial | 35 | 6% |
Peroneal | 11 | 2% |
Study details
- Retrospective, non-randomized, multi-center analysis
- Comparing GORE® PROPATEN® Vascular Graft and autologous saphenous vein
- There was no statistically significant difference in secondary patency or limb salvage between GORE® PROPATEN® Vascular Graft and autologous saphenous vein
…we had a 13% increase in secondary patency rates in ePTFE group, whereas the corresponding figure was only 6% in patients with occluded vein, thus confirming both the possibility of effectively treating occluded heparin-bonded grafts and the difficulty of dealing with occluded vein bypasses. — W. Dorigo
In patients with critical limb ischemia, the rates both of amputations at 4 years and of amputation-free survival were not different between autologous vein and heparin-bonded ePTFE…and this is an encouraging result, considering that limb salvage probably represents the main outcome in all these critical patients. — W. Dorigo
1. Dorigo W, Raffaele P, Piffaretti G. Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses. Journal of Cardiovascular Surgery 2012;53(2):187-193.